BECTON DICKINSON AND CO (BDX) Stock Price & Overview
NYSE:BDX • US0758871091
Current stock price
The current stock price of BDX is 156.69 USD. Today BDX is down by -1.23%. In the past month the price increased by 0.29%. In the past year, price decreased by -23.6%.
BDX Key Statistics
- Market Cap
- 44.616B
- P/E
- 11.27
- Fwd P/E
- 11.48
- EPS (TTM)
- 13.90
- Dividend Yield
- 2.71%
BDX Stock Performance
BDX Stock Chart
BDX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BDX. When comparing the yearly performance of all stocks, BDX is a bad performer in the overall market: 87.46% of all stocks are doing better.
BDX Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to BDX. BDX has an excellent profitability rating, but there are some minor concerns on its financial health.
BDX Earnings
On February 9, 2026 BDX reported an EPS of 2.91 and a revenue of 5.25B. The company beat EPS expectations (2.45% surprise) and beat revenue expectations (1.04% surprise).
BDX Forecast & Estimates
20 analysts have analysed BDX and the average price target is 206.41 USD. This implies a price increase of 31.73% is expected in the next year compared to the current price of 156.69.
For the next year, analysts expect an EPS growth of -12.75% and a revenue growth -12.56% for BDX
BDX Groups
Sector & Classification
BDX Financial Highlights
Over the last trailing twelve months BDX reported a non-GAAP Earnings per Share(EPS) of 13.9. The EPS decreased by -0.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.01% | ||
| ROA | 3.2% | ||
| ROE | 6.95% | ||
| Debt/Equity | 0.67 |
BDX Ownership
BDX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 14.76 | 166.816B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.16 | 165.367B | ||
| SYK | STRYKER CORP | 21.64 | 129.577B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.07 | 90.642B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.46 | 46.953B | ||
| IDXX | IDEXX LABORATORIES INC | 38.43 | 46.307B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.98 | 33.834B | ||
| RMD | RESMED INC | 18.02 | 32.944B | ||
| DXCM | DEXCOM INC | 24.61 | 24.87B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.93 | 18.482B | ||
| PODD | INSULET CORP | 29.66 | 13.912B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.58 | 13.095B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BDX
Company Profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
Company Info
IPO: 1963-09-25
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY 07417 US
CEO: Thomas E. Polen
Employees: 72000
Phone: 12018476800
BECTON DICKINSON AND CO / BDX FAQ
Can you describe the business of BECTON DICKINSON AND CO?
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
What is the current price of BDX stock?
The current stock price of BDX is 156.69 USD. The price decreased by -1.23% in the last trading session.
What is the dividend status of BECTON DICKINSON AND CO?
BECTON DICKINSON AND CO (BDX) has a dividend yield of 2.71%. The yearly dividend amount is currently 4.16.
What is the ChartMill rating of BECTON DICKINSON AND CO stock?
BDX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What do analysts say about BECTON DICKINSON AND CO (BDX) stock?
20 analysts have analysed BDX and the average price target is 206.41 USD. This implies a price increase of 31.73% is expected in the next year compared to the current price of 156.69.
How is the valuation of BECTON DICKINSON AND CO (BDX) based on its PE ratio?
The PE ratio for BECTON DICKINSON AND CO (BDX) is 11.27. This is based on the reported non-GAAP earnings per share of 13.9 and the current share price of 156.69 USD.
What is the outstanding short interest for BECTON DICKINSON AND CO?
The outstanding short interest for BECTON DICKINSON AND CO (BDX) is 3.35% of its float.